DAVOS, Switzerland (Reuters) - GlaxoSmithKline's chief executive, under pressure from some investors to break up the group, said on Thursday the drugmaker's large consumer healthcare unit had the ...

Emma Walmsley, the CEO who led the U.K. drugmaker GSK through the Covid-19 pandemic and the transformative spinoff of its consumer-health brands, will step down at the end of the year, the company ...

Consumer Healthcare. Watch videos, top stories and articles on Glaxosmithkline (gsk) Consumer Healthcare at moneycontrol.com.

(Reuters) -GSK's CEO Emma Walmsley will step down at the end of the year and be replaced by insider Luke Miels, the drugmaker said on Monday, a surprise switch as the British firm looks to rev up its ...

The FINANCIAL — GlaxoSmithKline (‘GSK’) and Maxinutrition Group Holdings Limited (‘Maxinutrition’) on December 13 announced they have entered into an agreement for GSK to acquire Maxinutrition, a UK ...

LONDON — GSK Chief Executive Emma Walmsley, the first woman to lead a major pharmaceutical company, will step down Dec. 31 after more than eight years at the head of the London-based drugmaker.

GSK plc is a leading global biopharmaceutical company with a diversified portfolio of vaccines and specialty medicines. The company focuses on innovation-driven growth, long-term research investment, ...

Recon: Pfizer to sell its stake in GSK consumer business after London listing; Sage postpartum depression drug hits goals in Phase III Welcome to Regulatory Reconnaissance, your daily regulatory news ...

CEO of Drugmaker GSK to Step Down by Year's End LONDON (AP) — GSK Chief Executive Emma Walmsley, the first woman to lead a major pharmaceutical company, will step down Dec. 31 after more than eight ...